COO NASDAQ
Credit Risk of going bust: lower than 69% of companies Debt: 18.0% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $1.11 (down 98%), The Cooper Companies, Inc. would be worth roughly what it owes.
Total debt $2.54B against a stock market value of $11.63B.
Distance to default 7.40 (Merton model): prices to 2026-10-26, balance sheet 2026-07-31, debt counted $1.59B (short-term plus half of long-term), stock volatility 32.3%; Altman Z 3.01. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
San Ramon, CA 94583
US
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Kurzius Lawrence Eri | P-Purchase | 10,000 | $54.93 | 2026-09-16 |
| Rosebrough Walter M | P-Purchase | 3,000 | $54.29 | 2026-09-14 |
| Kurzius Lawrence Eri | P-Purchase | 10,000 | $53.91 | 2026-09-14 |
| Rosebrough Walter M | P-Purchase | 7,000 | $54.11 | 2026-09-11 |
| Keel Paul A | P-Purchase | 4,701 | $53.18 | 2026-09-11 |